RESUMO
Rapid neurotransmission is mediated through a superfamily of Cys-loop receptors that includes the nicotinic acetylcholine (nAChR), gamma-aminobutyric acid (GABA(A)), serotonin (5-HT(3)) and glycine receptors. A class of ligands, including galanthamine, local anesthetics and certain toxins, interact with nAChRs non-competitively. Suggested modes of action include blockade of the ion channel, modulation from undefined extracellular sites, stabilization of desensitized states, and association with annular or boundary lipid. Alignment of mammalian Cys-loop receptors shows aromatic residues, found in the acetylcholine or ligand-binding pocket of nAChRs, are conserved in all subunit interfaces of neuronal nAChRs, including those that are not formed by alpha subunits on the principal side of the transmitter binding site. The amino-terminal domain containing the ligand recognition site is homologous to the soluble acetylcholine-binding protein (AChBP) from mollusks, an established structural and functional surrogate. We assess ligand specificity and employ X-ray crystallography with AChBP to demonstrate ligand interactions at subunit interfaces lacking vicinal cysteines (i.e. the non-alpha subunit interfaces in nAChRs). Non-competitive nicotinic ligands bind AChBP with high affinity (K(d) 0.015-6 microM). We mutated the vicinal cysteine residues in loop C of AChBP to mimic the non-alpha subunit interfaces of neuronal nAChRs and other Cys loop receptors. Classical nicotinic agonists show a 10-40-fold reduction in binding affinity, whereas binding of ligands known to be non-competitive are not affected. X-ray structures of cocaine and galanthamine bound to AChBP (1.8 A and 2.9 A resolution, respectively) reveal interactions deep within the subunit interface and the absence of a contact surface with the tip of loop C. Hence, in addition to channel blocking, non-competitive interactions with heteromeric neuronal nAChR appear to occur at the non-alpha subunit interface, a site presumed to be similar to that of modulating benzodiazepines on GABA(A) receptors.
Assuntos
Proteínas de Transporte/química , Proteínas de Transporte/metabolismo , Galantamina , Parassimpatomiméticos , Receptores Nicotínicos/química , Receptores Nicotínicos/metabolismo , Sequência de Aminoácidos , Animais , Aplysia , Sítios de Ligação , Proteínas de Transporte/genética , Cocaína/química , Cocaína/metabolismo , Cristalografia por Raios X , Galantamina/química , Galantamina/metabolismo , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Neurônios/metabolismo , Parassimpatomiméticos/química , Parassimpatomiméticos/metabolismo , Estrutura Quaternária de Proteína , Subunidades Proteicas/química , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Ensaio Radioligante , Receptores Nicotínicos/genética , Alinhamento de Sequência , Vasoconstritores/química , Vasoconstritores/metabolismoRESUMO
We have analysed hydrogen exchange at amide groups to characterise the energy landscape of the 72 amino acid residue protein MerP. From the guanidine hydrochloride (GuHCl) dependence of exchange in the pre-transitional region we have determined free energy values of exchange (DeltaG(HX)) and corresponding m-values for individual amide protons. Detailed analysis of the exchange patterns indicates that for one set of amide protons there is a weak dependence on denaturant, indicating that the exchange is dominated by local fluctuations. For another set of amide protons a linear, but much stronger, denaturant dependence is observed. Notably, the plots of free energy of exchange versus [GuHCl] for 16 amide protons show pronounced upward curvature, and a close inspection of the structure shows that these residues form a well-defined core in the protein. The hydrogen exchange that was measured at various concentrations of NaCl shows an apparent selective stabilisation of this core. Detailed analysis of this exchange pattern indicates that it may originate from selective destabilisation of the unfolded state by guanidinium ions and/or selective stabilisation of the core in the native state by chloride ions.
Assuntos
Guanidina/química , Hidrogênio/química , Conformação Proteica , Proteínas/química , Cloreto de Sódio/química , Amidas/química , Sequência de Aminoácidos , Guanidina/metabolismo , Modelos Moleculares , Dados de Sequência Molecular , Parassimpatomiméticos/química , Estrutura Secundária de Proteína , Proteínas/metabolismo , PrótonsRESUMO
Chewing of betel nut, the seed of Areca catechu, is associated with a host of physical and psychological effects while it is also traditionally used in constipation and hypertension. In this study, we report the cardio-selective cholinomimetic activity of the betel nut crude extract (Ac.Cr). Ac.Cr, that tested positive for saponins, tannins, phenols, alkaloids and terpenes, exhibited dose-dependent atropine-sensitive inhibition of isolated guinea-pig atrial contractility with an EC50 value of 0.93 microg/ml (0.57-1.51, 95% CI). In rabbit jejunum, Ac.Cr showed atropine-sensitive spasmogenicity with an EC50 of 7.31 microg/ml (5.41-9.88, 95% CI) showing that it is around 8 times more potent in the cardiac than the intestinal preparation. Both carbachol and physostigmine exhibited acetylcholine-like stimulant activity in jejunum with the latter being more potent in jejunum than in atrial tissues. Activity-directed fractionation of Ac.Cr yielded fractions with similar cholinergic activity in atria and jejunum except the aqueous fraction being 6 times more potent in the atria. Arecoline, the known betel nut compound with cholinergic activity showed similar potency in both tissues while catechin and tannic acid exhibited intestinal spasmolytic effect but were inactive in atria. The results show the cardio-selective inhibitory effect of Ac.Cr which might possibly be due to selective gut-spasmolytic behaviour of catechin and tannic acid thus reducing the cholinomimetic activity of Ac.Cr in the gut though the preferential binding of the constituents of betel nut extract at muscarinic receptor subtypes in heart cannot be ignored.
Assuntos
Antiarrítmicos/farmacologia , Areca/química , Alcaloides/farmacologia , Animais , Carbacol/química , Carbacol/farmacologia , Relação Dose-Resposta a Droga , Feminino , Cobaias , Técnicas In Vitro , Jejuno/efeitos dos fármacos , Masculino , Músculo Liso/efeitos dos fármacos , Parassimpatomiméticos/química , Parassimpatomiméticos/farmacologia , Fenóis/farmacologia , Fisostigmina/química , Fisostigmina/farmacologia , Extratos Vegetais/farmacologia , Coelhos , Padrões de Referência , Saponinas/farmacologia , Taninos/farmacologiaRESUMO
The X-ray structure of muscarone analogues 3 and 4 was determined and compared with that of muscarone (1, iodide and picrate salts), muscarine 2, dioxolane 5, oxathiolane 6, and tetrahydrofuran 7. In order to better define the pharmacological stereoselectivity of muscarone, the conformational profiles of compounds 1, 2, 3, and 5 were analyzed using Allinger's MM2(85) program or, in the case of 4, by 1H NMR spectroscopy. The conformation of the ring in 1 proved similar to that of the other derivatives. MM2 calculations predicted a preferred gauche arrangement of the side chain for 1 and its analogues; such an arrangement was also observed in the solid state of muscarone picrate. Thus, the antiperiplanar arrangement reported for crystalline muscarone iodide appears to be due to crystallographic packing forces. As a consequence, the rationalization of the pharmacological profile of 1 based on the antiperiplanar arrangement is now highly questionable. The lack of stereoselectivity of 4 can be attributed to the absence of a stereocenter at C-2 whereas, in our opinion, there are currently no sound explanations for the low values of eudismic ratios for the muscarone enantiomers.
Assuntos
Muscarina/análogos & derivados , Parassimpatomiméticos/química , Conformação Molecular , Muscarina/química , Estereoisomerismo , Difração de Raios XRESUMO
A series of 5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines+ ++ (7a-h) was synthesized for biological evaluation as selective agonists for M1 receptors coupled to phosphoinositide (PI) metabolism in the central nervous system. Each ligand bound with high affinity to muscarinic receptors from rat brain as measured by inhibition of [3H]-(R)-quinuclidinyl benzilate ([3H]-(R)-QNB) binding. 5-(3-Methyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine+ ++ trifluoroacetate (CDD-0098-J;7a) displayed high affinity (IC50 = 2.7 +/- 0.69 microM) and efficacy at muscarinic receptors coupled to PI metabolism in the rat cortex and hippocampus. Increasing the length of the alkyl substituent increased affinity for muscarinic receptors yet decreased activity in PI turnover assays. The hippocampal PI response of 7a was blocked by lower concentrations of pirenzepine (8) or by higher concentrations of either AF-DX 116 (9) or p-fluorohexahydrosiladifenidol (10), suggesting that at low concentrations 7a selectively stimulates PI turnover through M1 receptors.
Assuntos
Oxidiazóis/síntese química , Parassimpatomiméticos/síntese química , Pirimidinas/síntese química , Animais , Sítios de Ligação , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Oxidiazóis/química , Oxidiazóis/farmacologia , Parassimpatomiméticos/química , Parassimpatomiméticos/farmacologia , Pirimidinas/química , Pirimidinas/farmacologia , Quinuclidinil Benzilato/metabolismo , Ratos , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismo , Relação Estrutura-AtividadeRESUMO
The synthesis of 15 methyl or unsubstituted 1,2,3-triazoles, 1,2,4-triazoles, and tetrazoles additionally substituted with a 1-azabicyclo[2.2.2]octan-3-yl group is described. The potency and efficacy of these compounds as muscarinic ligands were determined in radioligand binding assays using [3H]oxotremorine and [3H]quinuclidinyl benzilate. Potency and efficacy were found in compounds in which the azole moiety was attached to the azabicyclic ring either through a carbon atom or a nitrogen atom. Electrostatic potential maps of both the C-linked and the novel N-linked series of compounds were calculated. A relationship between position and depth of the electrostatic minima relative to the azabicyclic ring and the potency and efficacy of the compounds was determined.
Assuntos
Parassimpatomiméticos/síntese química , Receptores Muscarínicos/metabolismo , Tetrazóis/síntese química , Triazóis/síntese química , Animais , Ligação Competitiva , Córtex Cerebral/metabolismo , Eletroquímica , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Oxotremorina/metabolismo , Parassimpatomiméticos/química , Parassimpatomiméticos/metabolismo , Quinuclidinil Benzilato/metabolismo , Ratos , Relação Estrutura-Atividade , Tetrazóis/química , Tetrazóis/metabolismo , Triazóis/química , Triazóis/metabolismoRESUMO
Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying high efficacy at cortical sites. The current paper describes the synthesis and biochemical assessment of semirigid muscarinic ligands which were used to map the requirements of the cortical muscarinic receptor and to study the degree of conformational flexibility required to cause receptor activation. Analogues 6 and 9 provide high-efficacy muscarinic agonists at cortical sites; however, C-alkylation on the tetrahydropyridine ring resulted in more rigid analogues and showed lower predicted efficacy. Molecular mechanics calculations indicated a preference for the E rotameric form. This conformation was also observed in the X-ray crystal structure of ethenyloxadiazole 12. The new compounds were tested in a biochemical assay designed to measure receptor affinity and to predict cortical efficacy.
Assuntos
Oxidiazóis/química , Parassimpatomiméticos/química , Piridinas/química , Receptores Muscarínicos/metabolismo , Animais , Sítios de Ligação , Fenômenos Químicos , Química , Cristalização , Ligação de Hidrogênio , Masculino , Conformação Molecular , Estrutura Molecular , Oxidiazóis/síntese química , Oxidiazóis/metabolismo , Parassimpatomiméticos/síntese química , Parassimpatomiméticos/metabolismo , Piridinas/síntese química , Piridinas/metabolismo , Ratos , Ratos Endogâmicos , Relação Estrutura-Atividade , Termodinâmica , Difração de Raios XRESUMO
A series of optically pure 2-[substituted-3-aminopropynyl]pyrrolidine derivatives, which are restricted-rotation analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5, compound 1), have been prepared from d- and l-proline. The compounds when tested in a series of in vitro muscarinic assays [[3H]CD (cortex), [3H]QNB (cortex), [3H]PZ (cortex), [3H]QNB (heart), [3H]QNB + GppNHp (heart)] were found to have weaker muscarinic properties than compound 1. The decrease in affinity was attributed to the increased size of the molecule resulting from the addition of a methylene group to form the pyrrolidine ring. The use of optically active compounds provided a more detailed examination of the complex pharmacological effects of the flexible muscarinic agent 1. The R enantiomers in the acetamide derivatives 12b, 12d, and 12f had a 5-10-fold greater affinity for the muscarinic receptor than the corresponding S enantiomers. A 5-fold difference or less found in the (R)- and (S)-carbamate derivatives 9, 15, and 16 suggested close overlap of the two enantiomers in the receptor binding domain. The affinity differences found in the enantiomeric acetamido derivatives when compared to those of the carbamate analogues may be the result of limited rotation of the acetamido group.
Assuntos
Parassimpatomiméticos/química , Pirrolidinas/química , Pirrolidinas/síntese química , Animais , Ligação Competitiva , Córtex Cerebral/metabolismo , Fenômenos Químicos , Química , Dioxolanos/metabolismo , Guanilil Imidodifosfato/farmacologia , Espectroscopia de Ressonância Magnética , Masculino , Conformação Molecular , Estrutura Molecular , Miocárdio/metabolismo , Parassimpatomiméticos/metabolismo , Parassimpatomiméticos/farmacologia , Pirenzepina/metabolismo , Pirrolidinas/metabolismo , Pirrolidinas/farmacologia , Quinuclidinil Benzilato/metabolismo , Ratos , Ratos Endogâmicos , Receptores Muscarínicos/metabolismo , Estereoisomerismo , Relação Estrutura-AtividadeRESUMO
Four regioisomers of 2-amino-(methoxycarbonyl)-3,4,5,6-tetrahydropyridine (2a-5a) were synthesized as the racemates to evaluate the utility of exocyclic amidines in the development of novel agonists for M1 muscarinic receptors. Of the four regioisomers, only racemic 2-amino-5-(methoxycarbonyl)-3,4,5,6-tetrahydropyridine (4a; CDD-0075-A) displayed high affinity (IC50 = 10 +/- 3.0 microM) and activity at muscarinic receptors coupled to PI metabolism in the rat cortex (260 +/- 4.5% stimulation above basal levels at 100 microM). A series of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines then was synthesized for further evaluation as M1 agonists. Only the propargyl derivative (4d) retained substantial agonist activity (120 +/- 14% at 100 microM) in this series. On the basis of the activity of the 5-(alkoxycarbonyl)-1,4,5,6- tetrahydropyrimidines (1a and 1d) and the 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines, the corresponding cyclic guanidine derivatives were synthesized and tested. 2-Amino-5-(methoxycarbonyl)-1,4,5,6-tetrahydropyrimidine (7a) displayed a modest affinity for muscarinic receptors in the CNS (22 +/- 5.3 microM) and an ability to stimulate PI turnover in rat cerebral cortex (81 +/- 16% at 100 microM). The propargyl derivative (7d) also had modest binding affinity (31 +/- 15 microM) and high activity (150 +/- 8.5% at 100 microM), as expected based on the activity of propargyl esters of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine. Computational chemical studies revealed five distinct minimum-energy conformations for 1a, (R)-4a, and 7a, and three for 1d, (R)-4d, and 7d, each with a unique orientation of the ester moiety. Each of the five conformations for 1a could be superimposed upon a unique conformer of (R)-4a and 7a, suggesting that the compounds interact with muscarinic receptors in a similar fashion. Taken together, the data indicate the general utility of amidine systems as suitable replacements for the ammonium group of acetylcholine in developing ligands with activity at M1 muscarinic receptors in the central nervous system. Such compounds might be useful in the treatment of patients with Alzheimer's disease.
Assuntos
Córtex Cerebral/metabolismo , Parassimpatomiméticos/química , Fosfatidilinositóis/metabolismo , Piridinas/química , Pirimidinas/química , Receptores Muscarínicos/fisiologia , Doença de Alzheimer/tratamento farmacológico , Animais , Córtex Cerebral/efeitos dos fármacos , Desenho de Fármacos , Humanos , Técnicas In Vitro , Indicadores e Reagentes , Inositol/metabolismo , Isomerismo , Cinética , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Modelos Moleculares , Conformação Molecular , Estrutura Molecular , Parassimpatomiméticos/síntese química , Parassimpatomiméticos/farmacologia , Piridinas/síntese química , Piridinas/farmacologia , Pirimidinas/síntese química , Pirimidinas/farmacologia , Ratos , Receptores Muscarínicos/efeitos dos fármacos , Espectrofotometria Infravermelho , Relação Estrutura-AtividadeRESUMO
A series of amide, urea, and carbamate analogues of the muscarinic (M1) ganglionic stimulant [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride (McN-A-343; 1) was prepared. The C1-methyl-substituted carbamates 8-11 were resolved into the enantiomers. In order to investigate the ganglionic stimulant activity and affinity of the new compounds we studied their ability to increase mean arterial blood pressure (MAP) in the pithed rat and their ability to displace the M1 receptor selective antagonist [3H]pirenzepine from rabbit sympathetic ganglia. The quaternary ammonium derivatives of 1, but not their corresponding tertiary amines, displayed ganglionic stimulant properties. The urea derivative 14 and the acetamide derivative 18 were almost equipotent to 1 as ganglionic agonists. In addition, 14 and 18 showed only 2- to 3-fold less affinity to ganglionic muscarinic receptors than 1. Introduction of a methyl group in the 1 position of the butynyl chain of 1 and its 4-chlorophenyl analogue increased ganglionic stimulant potency. The resulting (+/-)-9 and (+/-)-11 were the most potent analogues in this study. They were found to be partial agonists and showed 5- and 16-fold higher potency than 1, respectively, in increasing the MAP. They also displayed 6- and 18-fold higher affinity than 1 for ganglionic M1 receptors. The (S)-enantiomers of 9 and 11 were 1.5- and 4.9-fold more potent, respectively, than their antipodes as ganglionic muscarinic stimulants. The C1-methyl-substituted urea and acetamide derivatives (15 and 19) were 1.5- and 3-fold less potent than 1 and displayed several-fold lower affinity for ganglionic M1 receptors. The new quaternary analogues retained the selectivity for ganglionic muscarinic receptors since they produced weak partial agonist effects on the guinea pig ileum and showed several-fold lower nicotinic activity than 1 in the frog rectus abdominis assay.
Assuntos
Cloreto de (4-(m-Clorofenilcarbamoiloxi)-2-butinil)trimetilamônio/farmacologia , Parassimpatomiméticos/farmacologia , Cloreto de (4-(m-Clorofenilcarbamoiloxi)-2-butinil)trimetilamônio/química , Animais , Pressão Sanguínea/efeitos dos fármacos , Denervação , Gânglios/efeitos dos fármacos , Cobaias , Íleo/efeitos dos fármacos , Técnicas In Vitro , Masculino , Músculos/efeitos dos fármacos , Parassimpatomiméticos/química , Pirenzepina/metabolismo , Coelhos , Ranidae , Ratos , Ratos Endogâmicos , Receptores Muscarínicos/metabolismo , Relação Estrutura-Atividade , Especificidade por SubstratoRESUMO
A series of conformationally restricted analogues of the partial muscarinic agonist N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM 5; 1) was synthesized. Three of the racemic derivatives were resolved into the enantiomers. The compounds were investigated for muscarinic and antimuscarinic activity in the isolated guinea pig ileum. They were found to be fairly potent muscarinic antagonists or weak partial agonists. The new compounds were either equally or less potent than 1 in inhibiting (-)-[3H]-N-methylscopolamine binding in homogenates of the rat cerebral cortex. Thus, structural modifications to 1 in which the amide moiety and the methyl group in the butynyl chain have been joined to form a six- or seven-membered ring preserve affinity but abolish efficacy. The R enantiomers were found to have 14-79 times higher affinity to ileal muscarinic receptors than the respective antipodes. The enantiomeric affinity ratios were nearly identical in both preparations studied. As suggested by molecular mechanics calculations, the difference in affinity between the five-membered and the six- and seven-membered ring analogues may be rationalized in conformational terms.
Assuntos
Azepinas/química , Parassimpatomiméticos/química , Piperidinas/química , Pirrolidinas/química , Animais , Azepinas/metabolismo , Azepinas/farmacologia , Ligação Competitiva , Córtex Cerebral/metabolismo , Fenômenos Químicos , Química , Cobaias , Íleo/efeitos dos fármacos , Íleo/fisiologia , Espectroscopia de Ressonância Magnética , Masculino , Conformação Molecular , Estrutura Molecular , Contração Muscular/efeitos dos fármacos , N-Metilescopolamina , Parassimpatomiméticos/metabolismo , Parassimpatomiméticos/farmacologia , Piperidinas/metabolismo , Piperidinas/farmacologia , Pirrolidinas/metabolismo , Pirrolidinas/farmacologia , Ratos , Ratos Endogâmicos , Receptores Muscarínicos/metabolismo , Derivados da Escopolamina/metabolismo , EstereoisomerismoRESUMO
1. Recent theoretical studies have questioned the pharmacological estimation of agonist affinity. They showed that when receptor isomerisation or ternary complex mechanisms operate, the receptor inactivation method can substantially overestimate affinity, whereas methods for partial agonist analysis are more accurate. We previously suggested that the operation of such mechanisms and therefore the presence of errors could be detected by analysing the same partial agonist by the receptor inactivation and comparative methods. This paper describes the practical application of this test. 2. The ternary complex mechanism was simulated for a partial agonist under various conditions relating receptor (R) and transducer (T) concentrations, one of which also corresponds to the receptor isomerisation mechanism. The theoretical data so generated were then analysed by the inactivation and comparative methods to quantify the magnitude of error of affinity estimation that could occur. 3. This analysis showed that for a partial agonist with approximately 85% of the activity of a full agonist, the inactivation method could produce an affinity (pKA) estimate up to 0.7 log10 units higher than that produced by the comparative method. This difference would occur when the total receptor concentration ([R0]) is less than or equal to the total transducer concentration ([T0]). It also showed that the overestimation of affinity by the inactivation method was accompanied by drastic overestimation of Em, the maximal effect parameter. 4. The test was then exemplified using the muscarinic receptor system in the guinea-pig isolated left atrial preparation, where there is evidence that a ternary complex mechanism operates. The test agonist was pilocarpine, which produced on average 83% of the activity of the full agonist, carbachol. Pilocarpine was analysed in comparison with carbachol and by receptor inactivation in the same tissue resulting in small and statistically insignificant differences in Em (96.7% and 97.3% respectively) and pKA (5.03 and 4.95 respectively). 5. In conclusion, in this experimental system, there was no evidence for the errors in agonist affinity estimation predicted by theory. Although this conclusion only applies to this system and application of the test to others is necessary to establish the generality of the present results, further examination of the theoretical basis for the predicted errors is required.
Assuntos
Parassimpatomiméticos/farmacologia , Receptores Muscarínicos/efeitos dos fármacos , Animais , Carbacol/farmacologia , Simulação por Computador , Cobaias , Coração/efeitos dos fármacos , Técnicas In Vitro , Isomerismo , Cinética , Masculino , Parassimpatomiméticos/química , Pilocarpina/farmacologia , Receptores Muscarínicos/químicaRESUMO
The purpose of the study was to formulate a cisapride suspension that would be stable under usual storage conditions for 3 weeks. Cisapride is a new prokinetic agent that is available as a coated tablet; occasionally, however, patients require a liquid preparation of cisapride. Cisapride was formulated with propylene glycol to enhance its solubility. The suspension was buffered with sodium bicarbonate to produce a pH between 6.5 and 7.5. The formulation provided a cisapride suspension that was stable at room temperature for 3 weeks.
Assuntos
Química Farmacêutica , Parassimpatomiméticos/química , Piperidinas/química , Antioxidantes , Soluções Tampão , Cisaprida , Estabilidade de Medicamentos , Humanos , Concentração de Íons de Hidrogênio , Parassimpatomiméticos/normas , Veículos Farmacêuticos , Piperidinas/normas , Propilenoglicol , Propilenoglicóis , Bicarbonato de Sódio , Solubilidade , Suspensões , TemperaturaRESUMO
The preparation and the biological activities of the four stereoisomers of 3-[5-(3-amino-1,2,4-oxadiazol)yl]-1-azabicyclo[2.2.1]heptane are described. The most potent stereoisomer, 3a, has the 3R,4R configuration, and in vitro activities in (pD2(% efficacy): ileum 8.8 (87%), hippocampus 9.8 (116%) and ganglion 10.2 (36%)). 3b (3S,4S) was weaker (ileum 8.1 (121%), hippocampus 8.5 (107%), ganglion 9.0 (63%)). The other two stereoisomers, 4a (3S,4R; ileum 7.1 (108%), hippocampus 8.2 (116%), ganglion 7.3 (31%)) and 4b (3R,4S; ileum 7.0 (100%), hippocampus 7.0 (120%), ganglion 7.2 (67%)) are of comparable activity, with an analogous profile to that of the more potent stereoisomers. Thus, compounds 3a and 4a, possessing the 4R stereochemistry, showed selectivity for the hippocampus over the ileum. Compound 3a was, however, more potent in the ganglion than in the hippocampus. All four stereoisomers were full agonists in the hippocampus, indicating M1 activity; however, they were partial agonists in the depolarisation of the rat superior cervical ganglion, another M1-mediated response. This may be due to M2-mediated hyperpolarization. With 3a (0.01 mg/kg i.p.), expression of c-fos mRNA was observed in the hypothalamus and in brain areas involved in sensory processing; these effects were totally blocked by pretreatment with 2 mg/kg scopolamine. In particular, activation of the superior colliculus is consistent with potent M2 activity.
Assuntos
Compostos Bicíclicos Heterocíclicos com Pontes , Gânglios Simpáticos/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Íleo/efeitos dos fármacos , Oxidiazóis/farmacologia , Parassimpatomiméticos/farmacologia , Receptores Muscarínicos/metabolismo , Animais , Sítios de Ligação , Gânglios Simpáticos/metabolismo , Expressão Gênica , Genes fos , Cobaias , Hipocampo/metabolismo , Íleo/metabolismo , Técnicas In Vitro , Masculino , Hibridização de Ácido Nucleico , Oxidiazóis/síntese química , Oxidiazóis/química , Parassimpatomiméticos/síntese química , Parassimpatomiméticos/química , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores Muscarínicos/efeitos dos fármacos , Escopolamina/farmacologia , EstereoisomerismoRESUMO
The muscarinic agonist oxotremorine and the tricyclic muscarinic antagonists pirenzepine and telenzepine have been derivatized using a functionalized congener approach for the purpose of synthesizing high affinity ligand probes that are suitable for conjugation with prosthetic groups, for receptor cross-linking, fluorescent and radioactive detection, etc. A novel fluorescent conjugate of TAC (telenzepine amine congener), an n-decylamino derivative of the m1-selective antagonist, with the fluorescent trisulfonated pyrene dye Cascade Blue may be useful for assaying the receptor as an alternative to radiotracers. In a rat m3 receptor mutant containing a single amino acid substitution in the sixth transmembrane domain (Asn507 to Ala) the parent telenzepine lost 636-fold in affinity, while TAC lost only 27-fold. Thus, the decylamino group of TAC stabilizes the bound state and thus enhances potency by acting as a distal anchor in the receptor binding site. We have built a computer-assisted molecular model of the transmembrane regions of muscarinic receptors based on homology with the G-protein coupled receptor rhodopsin, for which a low resolution structure is known. We have coordinated the antagonist pharmacophore (tricyclic and piperazine moieties) with residues of the third and seventh helices of the rat m3 receptor. Although the decylamino chain of TAC is likely to be highly flexible and may adopt many conformations, we located one possible site for a salt bridge formation with the positively charged -NH3+ group, i.e. Asp113 in helix II.
Assuntos
Técnicas de Sonda Molecular , Antagonistas Muscarínicos/farmacologia , Receptores Muscarínicos/metabolismo , Animais , Fluorescência , Proteínas de Ligação ao GTP/metabolismo , Ligantes , Modelos Moleculares , Estrutura Molecular , Antagonistas Muscarínicos/química , Mutagênese Sítio-Dirigida , Oxotremorina/química , Oxotremorina/farmacologia , Parassimpatomiméticos/química , Parassimpatomiméticos/farmacologia , Pirenzepina/análogos & derivados , Pirenzepina/química , Pirenzepina/farmacologia , Ratos , Receptores de Superfície Celular/metabolismo , Receptores Muscarínicos/químicaRESUMO
Alkylthio-TZTPs (3-(3-alkylthio-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-met hylpyridines) and corresponding azabicyclic analogs were tested for m1 efficacy in cloned human m1 receptors and for antinociceptive activity in the mouse grid shock assay. The m1 (%PI) SAR were distinctly different from the analgesia and the salivation SAR, suggesting that analgesia is mediated by neither m1 nor M3 muscarinic receptors.
Assuntos
Analgésicos/farmacologia , Agonistas Muscarínicos/farmacologia , Parassimpatomiméticos/farmacologia , Piridinas/farmacologia , Receptores Muscarínicos/metabolismo , Tiadiazóis/farmacologia , Analgésicos/química , Animais , Carbacol/farmacologia , Relação Dose-Resposta a Droga , Humanos , Concentração Inibidora 50 , Camundongos , Estrutura Molecular , Agonistas Muscarínicos/química , Limiar da Dor/efeitos dos fármacos , Limiar da Dor/fisiologia , Parassimpatomiméticos/química , Fosfatidilinositóis/metabolismo , Piridinas/química , Receptor Muscarínico M1 , Salivação/efeitos dos fármacos , Relação Estrutura-Atividade , Tiadiazóis/química , Vocalização Animal/efeitos dos fármacosRESUMO
The muscarinic pharmacology of C1-methyl-substituted chiral compounds related to McN-A-343 and of (R)- and (S)-dimethindene has been studied. Among the McN-A-343 analogues, the (S)-enantiomers were more potent and had higher affinity than the (R)-isomers. The quaternary compound (S)-BN 228 was found to be the most potent M1-selective agonist known today (pEC50: M1/rabbit vas deferens = 7.83; M2/guinea-pig atria = 6.35; M3/guinea-pig ileum = 6.29). In both the atria and ileum the tertiary carbamate, (S)-4-F-MePyMcN, was a competitive antagonist (pA2 value = 7.39 and 6.82, respectively). In contrast, in rabbit vas deferens (S)-4-F-MePyMcN was a potent partial agonist (pEC50 = 7.22; apparent efficacy = 0.83). These results indicate that (S)-4-F-MePyMcN might be a useful tool to study M1 receptor-mediated effects involved in central cholinergic function. (S)-Dimethindene was a potent M2-selective antagonist (pA2 = 7.86/atria; pKi = 7.8/rat heart) with lower affinities for the M1 (pA2 = 6.36/rat duodenum; pKi = 7.1/NB-OK 1 cells), M3 (pA2 = 6.92/guinea-pig ileum; pKi = 6.7/rat pancreas) and M4 receptors (pKi = 7.0/rat striatum). It was more potent (up to 41-fold) than the (R)-isomer. In contrast, the stereoselectivity was inverse at ileal H1 receptors (pA2: (R)-isomer = 9.42; (S)-isomer = 7.48). Thus, (S)-dimethindene could be a valuable agent to test the hypothesis that M2 antagonists show beneficial effects in the treatment of cognitive disorders. It might also become the starting point for the development of diagnostic tools for quantifying M2 receptors in the CNS with PET imaging.
Assuntos
Cloreto de (4-(m-Clorofenilcarbamoiloxi)-2-butinil)trimetilamônio/farmacologia , Dimetideno/farmacologia , Agonistas Muscarínicos/farmacologia , Antagonistas Muscarínicos/farmacologia , Cloreto de (4-(m-Clorofenilcarbamoiloxi)-2-butinil)trimetilamônio/análogos & derivados , Cloreto de (4-(m-Clorofenilcarbamoiloxi)-2-butinil)trimetilamônio/química , Animais , Benzodiazepinas/química , Benzodiazepinas/farmacologia , Linhagem Celular , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/metabolismo , Dimetideno/análogos & derivados , Dimetideno/química , Desenho de Fármacos , Cobaias , Átrios do Coração/efeitos dos fármacos , Átrios do Coração/metabolismo , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Agonistas Muscarínicos/química , Antagonistas Muscarínicos/química , Músculo Liso/efeitos dos fármacos , Músculo Liso/metabolismo , Pâncreas/efeitos dos fármacos , Pâncreas/metabolismo , Parassimpatomiméticos/química , Parassimpatomiméticos/farmacologia , Pirrolidinas/química , Pirrolidinas/farmacologia , Coelhos , Ratos , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismo , Relação Estrutura-AtividadeRESUMO
The history of "slobbers syndrome," a mycotoxicosis associated with Rhizoctonia leguminicola infestation of pastures and stored forages, is discussed. The chemistry and physiological effects of the two known biologically active alkaloids of R. leguminicola, slaframine and swainsonine, are described. Slaframine administration is generally associated with increased exocrine function, especially salivation. Ingestion of swainsonine may be linked to serious and potentially lethal central nervous system defects similar to that described for locoism. However, the singular effects of these alkaloids do not completely account for the total clinical picture noted in the field during the occurrence of slobbers syndrome. It is possible that this phenomenon is the result of an interaction between both known and unidentified biologically active metabolites of R. leguminicola.
Assuntos
Alcaloides/farmacologia , Doenças dos Bovinos/etiologia , Micotoxicose/veterinária , Parassimpatomiméticos/farmacologia , Sialorreia/veterinária , Swainsonina/farmacologia , Alcaloides/química , Animais , Bovinos , Doenças dos Bovinos/fisiopatologia , Sistema Nervoso Central/fisiologia , Micotoxicose/etiologia , Micotoxicose/fisiopatologia , Parassimpatomiméticos/química , Poaceae/microbiologia , Rhizoctonia/isolamento & purificação , Salivação/fisiologia , Sialorreia/etiologia , Sialorreia/fisiopatologia , Swainsonina/química , SíndromeRESUMO
The two enantiomers of the potent muscarinic ligand 2-methyl-5[(dimethylamino)methyl]-3-oxo-isoxazolidine methiodide [(+/-)-V] were synthesized in a very high enantiomeric excess (98.8 and greater than 99%). The muscarinic activity of the two enantiomers was assayed on the isolated guinea pig ileum and atria, and on rat jejunum and urinary bladder and the nicotinic activity was evaluated on the frog rectus abdominis muscle. (R)-(-)-V, the most potent enantiomer in the muscarinic tests, has the same absolute configuration as [2R,5R]-muscarone and, like muscarone, has a low eudismic ratio (ER: 2.5-10.4). In the nicotinic assay, (S)-(+)-V was found to be the eutomer (ER: 3.5).
Assuntos
Isoxazóis/síntese química , Parassimpatomiméticos/síntese química , Animais , Cobaias , Átrios do Coração/efeitos dos fármacos , Íleo/efeitos dos fármacos , Técnicas In Vitro , Isoxazóis/química , Isoxazóis/farmacologia , Jejuno/efeitos dos fármacos , Masculino , Músculo Liso/efeitos dos fármacos , Parassimpatomiméticos/química , Parassimpatomiméticos/farmacologia , Rana esculenta , Ratos , Ratos Endogâmicos , Receptores Muscarínicos/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacos , Estereoisomerismo , Bexiga Urinária/efeitos dos fármacosRESUMO
The interactions on antinociception between a muscarinic agonist arecoline (arec), an anticholinesterase physostigmine (physo) which both cross CNS, and a peripherally acting antimuscarinic hyoscine-N-butyl bromide (hyo), were assessed by tail flick test in mice. All drugs were administered intraperitoneally (i.p.). While hyoscine-N-butyl bromide (0.15 and 4.00 mg/kg, i.p.) did not produce antinociception, physostigmine salicylate (0.3 mg/kg, i.p.) and arecoline hydrobromide (8.00 mg/kg, i.p.) exerted significant antinociceptive effect. In combined applications, physo + hyo (0.075 + 0.15; 0.15 + 0.30; 0.30 + 0.60 mg/kg) and arec + hyo (1.00 + 0.50; 2.00 + 1.00; 4.00 + 2.00; 8.00 + 4.00 mg/kg), respectively, produced significant antinociception and the tail flick latencies produced by physo 0.30 + hyo 0.60 mg/kg and arec 8.00 + hyo 4.00 mg/kg were not significantly different from those of physo 0.30 mg/kg and arec 8.00 mg/kg, respectively, showing that hyo did not antagonise the antinociceptive effects of physo and arec. We believe that combining an centrally acting cholinergic drug applied systemically with a peripherally acting (quaternary amine) antimuscarinic compound might be used as an effective analgesic in clinical practice.